Pancreatic cancer data will be good, just have to wait a bit more. Good results from mFOLFIRINOX safety trial hopefully before EOY. GLTA. All new analysts targets are higher and rated overweight.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more